In this month's roundtable industry and government experts provide insights on the recently revised 42 CFR Part 2 regulations governing the confidentiality of substance abuse treatment and prevention records. This panel will offer a broad discussion of the new regulations, their impact on care coordination and the broader healthcare community.
Michael Lardieri, LCSW
Assistant Vice President, Strategic Program Development
Behavioral Health Service Line
Kimberly A. Johnson, Ph.D.
Director, Center for Substance Abuse Treatment (CSAT)
Substance Abuse and Mental Health Services Administration (SAMHSA)
Renée Popovits, J.D.
Popovits Law Group, P.C.